AI Verdict
HQY has stronger fundamentals based on our AI analysis.
HRGN vs HQY Fundamental Comparison
| Metric | HRGN | HQY |
|---|---|---|
| Revenue | $704,000.0 | $1.3B |
| Net Income | $-6.9M | $215.2M |
| Net Margin | -975.7% | 16.4% |
| ROE | -649.9% | 10.2% |
| ROA | -256.6% | 6.4% |
| Current Ratio | 1.19x | 3.27x |
| Debt/Equity | 0.00x | 0.45x |
| EPS | $-0.44 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRGN vs HQY: Frequently Asked Questions
Is HRGN or HQY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HQY has stronger fundamentals. HRGN is rated STRONG SELL (85% confidence) while HQY is rated BUY (82% confidence). This is not investment advice.
How does HRGN compare to HQY fundamentally?
Harvard Apparatus Regenerative Technology, Inc. has ROE of -649.9% vs HEALTHEQUITY, INC.'s 10.2%. Net margins are -975.7% vs 16.4% respectively.
Which stock pays higher dividends, HRGN or HQY?
HRGN has a dividend yield of N/A or no dividend while HQY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRGN or HQY for long term?
For long-term investing, consider that HRGN has STRONG SELL rating with 85% confidence, while HQY has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRGN vs HQY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRGN vs HQY, the AI consensus favors HQY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.